Vivos Inc (RDGL) income statement
RDGLOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 9/30
$0.05−0.00 (-2.51%)
Close on Oct 19, 2026Market cap $23.44MP/E –Yield –
Vivos Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- -25.9%
- Operating margin
- -2852.5%
- Net margin
- -3633.6%
- Return on equity, FY2025
- -161.0%
Financial strength
- Current ratio
- 48.85
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 4674.6%
Valuation
- P/E ratio
- –
- Price to sales
- 236.54
- Price to book
- 8.51
- Dividend yield
- –
See a number that looks wrong?